$8.27
-0.73 (-8.11%)
Open$8.26
Previous Close$9.00
Day High$8.27
Day Low$8.25
52W High$302.40
52W Low$6.45
Volume—
Avg Volume15.6K
Market Cap110.17M
P/E Ratio—
EPS$-0.13
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.46M | 5.33M | 106.35M |
| Net Income | -2,345,972 | -2,524,963 | 12.42M |
| Profit Margin | -52.6% | -50.0% | 11.7% |
| EBITDA | -1,308,202 | -1,486,237 | 22.69M |
| Free Cash Flow | — | — | 8.29M |
| Rev Growth | -16.4% | -16.4% | +7.5% |
| Debt/Equity | 0.00 | 0.00 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |